documents: FDA-1995-N-0225-0003
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1995-N-0225-0003 | FDA | FDA-1995-N-0225 | Reference 1 - Letter dated June 20, 1992, from R. W.Soller, Nonprescription Drug Manufacturers Association, to W. E. Gilbertson, FDA, in OTC Vol. 190036, Docket No. 95N 0062, Dockets Management Branch. | Supporting & Related Material | Background Material | 2017-02-01T05:00:00Z | 2017 | 2 | 2024-07-30T15:17:55Z | 0 | 0 | 09000064824a4be6 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref